Medicine and Dentistry
Age
11%
Analysis
46%
Antithrombotic
9%
Apoplexy
9%
Assessment
10%
Association
10%
Breast
7%
Breast Cancer
43%
Cancer Registry
8%
Chemotherapeutic Agent
9%
Child
22%
Chronic Obstructive Pulmonary Disease
9%
Colorectal Cancer Screening
18%
Combination Therapy
35%
Decision Making
16%
Diagnosis
9%
Disability
11%
Disease
11%
Disease Free Survival
10%
Drug
9%
Follow up
17%
Health
13%
Health Care
13%
Health Care Cost
7%
Hip Fracture
14%
Infant
9%
Inpatient
27%
Learning
9%
Lung Cancer Screening
9%
Measurement
7%
Monitoring
9%
Mortality
15%
Parkinson's Disease
9%
Patient
100%
Patient Preference
23%
Pediatrics
9%
Peroneus Nerve Paralysis
9%
Primary Health Care
13%
Randomized Controlled Trial
19%
Recurrence Risk
8%
Recurrent Disease
10%
Screening
30%
Skull
18%
Surgery
16%
Surveillance
6%
Survival
9%
Systematic Review
9%
Technology Assessment
9%
Therapeutic Procedure
40%
Woman
18%
Nursing and Health Professions
Adult
10%
Analysis
42%
Anticoagulant Agent
7%
Anticoagulant Therapy
10%
Atrial Fibrillation
9%
Breast Cancer
8%
Cancer Screening
13%
Case Study
14%
Child
7%
Colorectal Cancer
13%
Combination Therapy
27%
Decision Support System
5%
Diseases
12%
Drug
6%
Error
6%
Experiment
38%
Health Service
5%
Health Status
11%
Helmet
13%
Hip Fracture
9%
Low Back Pain
9%
Measurement
10%
Monitoring
9%
Mortality
14%
Obstructive Lung Disease
13%
Odds Ratio
5%
Parent
5%
Parkinson Disease
23%
Patient
32%
Patient Compliance
5%
Patient Preference
15%
Pediatrics
5%
Pilot Study
9%
Population
10%
Prediction
6%
Primary Medical Care
9%
Procedures
20%
Quality of Life
11%
Reliability
6%
Sample
11%
Screening
12%
Side Effect
7%
Statistical Analysis
5%
Time
19%
Visual Analog Scale
9%
Weight
13%
Social Sciences
Adults
9%
Alternative
5%
Analysis
14%
Approach
13%
Cancer
5%
Case Studies
5%
Choice Experiment
29%
Conjoint Analysis
9%
Costs
5%
Decision
9%
Difference
12%
Discrete Choice
6%
Dutch
7%
Health
13%
Health Care
6%
Identity
13%
Information
5%
Multiple-Criteria Decision Analysis
5%
Netherlands
9%
Outcomes Research
6%
Patients
18%
Perspective
11%
Poland
5%
Quality of Life
5%
Relative
5%
Scaling
5%
Testing
13%
Time
5%
Uncertainty
6%
